10 Analysts Have This to Say About Merck & Co – Merck & Co (NYSE:MRK)
Merck & Co. M.K.R. observed the following analyst notes during the last quarter:
|Bullish||Rather bullish||Indifferent||a bit bearish||Bearish|
|last 30 days||0||1||0||0||0|
|2 months ago||0||0||0||0||0|
|3 months ago||0||4||3||0||0|
According to 10 analysts offering 12-month price targets over the past 3 months, Merck & Co has an average price target of $101.5 with a high of $110.00 and a low of $88.00.
Below is a summary of how these 10 analysts have rated Merck & Co over the past 3 months. The higher the number of bullish ratings, the more analysts are positive on the security and the higher the number of bearish ratings, the more analysts are negative on the security
This current average is up 6.28% from the previous average price target of $95.50.
Analysts work in banking and financial systems and typically specialize in reporting on stocks or defined sectors. Analysts can attend company conference calls and meetings, research company financials, and communicate with insiders to issue “analyst notes” for stocks. Analysts typically rate each stock once a quarter.
Some analysts also offer forecasts for useful metrics such as earnings, revenue, and growth estimates to provide additional guidance on what to do with certain tickers. It is important to keep in mind that although stock and sector analysts are specialists, they are also human and can only predict their opinions to traders.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.